Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia.

Ny, S ; Kozlov, R ; et al.

In: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, Jg. 37 (2018-12-01), Heft 12, S. 2347-2354

Online academicJournal

Wie komme ich dran?

Zugriff:

Zum Volltext

We investigated the faecal carriage prevalence of extended-spectrum β-lactamase production in Escherichia coli (EP-EC) and/or Klebsiella pneumoniae (EP-KP) and risk factors associated with carriage among adult study subjects in Finland, Germany, Latvia, Poland, Russia and Sweden (partner countries). The aim was to get indicative data on the prevalence of ESBL-carriage in specific populations in the region. Faecal samples were collected from four study populations and screened on ChromID-ESBL and ChromID-OXA-48 plates. Positive isolates were further characterised phenotypically. Our results show a large variation in carrier prevalence ranging from 1.6% in Latvia to 23.2% in Russia for EP-EC. For the other partner countries, the prevalence of EP-EC were in increasing numbers, 2.3% for Germany, 4.7% for Finland, 6.6% for Sweden, 8.0% for Poland and 8.1% for all partner countries in total. Carriers of EP-KP were identified only in Finland, Russia and Sweden, and the prevalence was < 2% in each of these countries. No carriers of carbapenemase-producing isolates were identified. This is the first study reporting prevalence of carriers (excluding traveller studies) for Finland, Latvia, Poland and Russia. It contributes with important information regarding the prevalence of EP-EC and EP-KP carriage in regions where studies on carriers are limited.

Titel:	Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia.
Autor/in / Beteiligte Person:	Ny, S ; Kozlov, R ; Dumpis, U ; Edquist, P ; Gröndahl-Yli-Hannuksela, K ; Kling, AM ; Lis, DO ; Lübbert, C ; Pomorska-Wesołowska, M ; Palagin, I ; Vilde, A ; Vuopio, J ; Walter, J ; Wisell, KT
Link:	Zum Volltext
Zeitschrift:	European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, Jg. 37 (2018-12-01), Heft 12, S. 2347-2354
Veröffentlichung:	Berlin : Springer ; <i>Original Publication</i>: [Wiesbaden, Federal Republic of Germany] : Vieweg, [c1988-, 2018
Medientyp:	academicJournal
ISSN:	1435-4373 (electronic)
DOI:	10.1007/s10096-018-3382-8
Schlagwort:	Adult Anti-Bacterial Agents pharmacology Bacterial Proteins metabolism Cross-Sectional Studies Drug Resistance, Multiple, Bacterial Escherichia coli enzymology Europe epidemiology Female Humans Klebsiella pneumoniae enzymology Male Microbial Sensitivity Tests Middle Aged Prevalence Risk Factors Russia epidemiology Young Adult beta-Lactamases metabolism Asymptomatic Infections epidemiology Escherichia coli isolation & purification Escherichia coli Infections epidemiology Feces microbiology Klebsiella Infections epidemiology Klebsiella pneumoniae isolation & purification
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Corporate Authors: NoDARS ESBL-carrier working group Publication Type: Journal Article Language: English [Eur J Clin Microbiol Infect Dis] 2018 Dec; Vol. 37 (12), pp. 2347-2354. <i>Date of Electronic Publication: </i>2018 Oct 18. MeSH Terms: Asymptomatic Infections / epidemiology ; Escherichia coli / isolation & purification ; Escherichia coli Infections / epidemiology ; Feces / microbiology ; Klebsiella Infections / epidemiology ; Klebsiella pneumoniae / isolation & purification ; Adult ; Anti-Bacterial Agents / pharmacology ; Bacterial Proteins / metabolism ; Cross-Sectional Studies ; Drug Resistance, Multiple, Bacterial ; Escherichia coli / enzymology ; Europe / epidemiology ; Female ; Humans ; Klebsiella pneumoniae / enzymology ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Prevalence ; Risk Factors ; Russia / epidemiology ; Young Adult ; beta-Lactamases / metabolism References: Folia Microbiol (Praha). 2003;48(2):243-7. (PMID: 12800510) ; Antimicrob Agents Chemother. 2003 Dec;47(12):3724-32. (PMID: 14638473) ; Clin Microbiol Rev. 2013 Oct;26(4):744-58. (PMID: 24092853) ; Clin Infect Dis. 2015 Mar 15;60(6):837-46. (PMID: 25613287) ; Scand J Infect Dis. 2014 Nov;46(11):753-62. (PMID: 25195648) ; Lancet Infect Dis. 2017 Jan;17(1):78-85. (PMID: 27751772) ; J Antimicrob Chemother. 2017 Feb;72(2):582-588. (PMID: 27798205) ; Clin Infect Dis. 2013 Feb;56(4):478-87. (PMID: 23243181) ; Int J Environ Res Public Health. 2017 Jun 23;14(7):. (PMID: 28644413) ; Int J Med Microbiol. 2015 Jan;305(1):148-56. (PMID: 25547265) ; Clin Infect Dis. 2009 Sep 1;49(5):682-90. (PMID: 19622043) ; Clin Infect Dis. 2015 Jun 1;60(11):1622-30. (PMID: 25694654) ; Clin Infect Dis. 2016 Aug 1;63(3):310-8. (PMID: 27143671) ; Antimicrob Agents Chemother. 2014;58(2):1228-30. (PMID: 24295972) ; Int J Infect Dis. 2012 May;16(5):e371-4. (PMID: 22401750) ; Clin Microbiol Infect. 2012 Mar;18(3):268-81. (PMID: 21793988) ; Antimicrob Agents Chemother. 2010 Sep;54(9):3564-8. (PMID: 20547788) ; Emerg Infect Dis. 2016 Apr;22(4):634-40. (PMID: 26982890) Grant Information: 2014/344-660 European Commission Contributed Indexing: Investigator: K Rantakokko-Jalava; M Gunell; E Rintala; H Marttila; T Kurvinen; E Lönnqvist; M Virta; AM Kaarto; M Talja; T Eckmanns; MA Sin; E Velasco; AC Rodloff; FS Lempp; N Lippmann; N Ivanchik; O Dyar; C Giske; PZ Brewczyński; L Horoń; A Kantele; SH Pakkanen ; Keywords: Antibiotic resistance; Asymptomatic carriage; E. coli; ESBL; K. pneumoniae Europe and Russia Substance Nomenclature: 0 (Anti-Bacterial Agents) ; 0 (Bacterial Proteins) ; EC 3.5.2.6 (beta-Lactamases) ; EC 3.5.2.6 (carbapenemase) Entry Date(s): Date Created: 20181020 Date Completed: 20190211 Latest Revision: 20190215 Update Code: 20231215

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.